What is Tales of the Immortal Path?
Tales of the Immortal Path trades tight tactical precision for a chaotic, god-tier power fantasy wrapped in stunning ink-wash art. You aren't just building a deck; you're cultivating a path to immortality by chaining broken artifact synergies that turn every run into a unique spectacle of destruction.
Gameplay
You’re diving into Tales of the Immortal Path, a $3.99 ink-wash xianxia roguelike that scratches that specific deckbuilding itch. The core loop isn’t just about slapping down high-damage cards; it’s about constructing a 'Dao' through massive artifact and card synergies. You’ll find yourself chaining triggers where one card sparks a cascade of attacks, giving you that 'everything explodes' power fantasy reminiscent of Monster Train. The run variety stays fresh because the artifact pool is massive, so you rarely repeat the same build. However, the game is rough around the edges. The UI feels clunky, and some card descriptions are poorly translated, leaving you to guess how modifiers actually work until you test them in battle. It’s less of a tight puzzle like Slay the Spire and more of a chaotic power trip where you’re trying to become a god rather than just survive.
Key Features
- Ink-wash xianxia visual style
- Massive artifact synergy combos
- Permanent ascension progression
- Chaos-driven power fantasy loop
- Clunky UI and translation issues
Screenshots
Verdict
“Simple but entertaining. I'm a sucker for Wuxia style games so I jumped on this considering it's price. I got one playthrough done on this as alchemist and I can safely say I enjoyed feeling OP by mid…”
Grab this if you love chaotic synergies and don't mind a bit of UI friction or translation confusion. Skip it if you need polished tutorials and tight, puzzle-like strategy, as this game is about embracing the chaos of becoming a god. At $3.99, it’s a solid buy for fans of the genre, even if it’s not quite ready for prime time.
View on Steam →* Price at time of publication (checked 18.10.2026). Prices may vary by region and are subject to change. This is an editorial review, not a commercial offer.